Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy

ClinicalTrials.gov ID: NCT05875974

Public ClinicalTrials.gov record NCT05875974. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 1:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Open-Label, Single-Arm, Multicenter Study to Evaluate the Effect of Low-Sodium Oxybate Oral Solution (XYWAV) on Sleepiness, Polysomnography, and Functional Outcomes in Adult Participants Aged 18 to 75 Years With Idiopathic Hypersomnia or Narcolepsy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will assess the safety and efficacy of JZP258 (XYWAV) on sleepiness, polysomnography, and functional outcomes in patients with idiopathic hypersomnia (IH) or narcolepsy.

Study identification

NCT ID
NCT05875974
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Jazz Pharmaceuticals
Industry
Enrollment
199 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 27, 2023 (Actual)
Primary completion
Mar 13, 2025 (Actual)
Completion
Mar 13, 2025 (Actual)
Last update posted
Aug 27, 2026

2023 – 2025

United States locations

U.S. sites
29
U.S. states
13
U.S. cities
28
Facility City State ZIP Site status
Sleep Disorders Center of Alabama Birmingham Alabama 35213 —
Perseverance Research Center, LLC Scottsdale Arizona 85253 —
Amnova Clinical Research Irvine California 92604 —
Long Beach Research Institute Lakewood California 90805 —
Santa Monica Clinical Trials Los Angeles California 90025 —
Stanford School of Medicine Redwood City California 94063 —
TriValley Sleep Center San Ramon California 94583 —
SDS Clinical Trials, Inc. Santa Ana California 92705 —
Meris Clinical Research, LLC Brandon Florida 33511 —
PharmaDev Clinical Research Institute, LLC Miami Florida 33176 —
Florida Hospital for Children Winter Park Florida 32789 —
NeuroTrials Research, Inc. Atlanta Georgia 30328 —
Centricity Research Rincon - DBA IACT Health Southeast Lung Associates Research Rincon Georgia 31326 —
Neurocare, Inc., dba Neurocare Center for Research Newtown Massachusetts 02459 —
Clinical Neurophysiology Services, P.C. Sterling Heights Michigan 48314 —
St. Lukes Hospital Medical Center Chesterfield Missouri 63017 —
Clinical Research of Gastonia Gastonia North Carolina 28054 —
Stern Research Partners, LLC Huntersville North Carolina 28078 —
CTI Clinical Research Center Cincinnati Ohio 45212 —
Intrepid Research Cincinnati Ohio 45245 —
Cleveland Clinic Main Campus - Clinical Research Unit Cleveland Ohio 44195 —
Ohio Sleep Medicine and Neuroscience Institute Dublin Ohio 43017 —
Abington Neurological Associates, LTD Abington Pennsylvania 19001 —
Geisinger Clinic Scranton Pennsylvania 18510 —
Bogan Sleep Consultants, LLC Columbia South Carolina 29201 —
FutureSearch Trials of Neurology Austin Texas 78731 —
Comprehensive Sleep Medicine Associates Houston Texas 77030 —
Sleep Therapy & Research Center San Antonio Texas 78229 —
Tricoastal Narcolepsy and Sleep Disorders Center Sugar Land Texas 77479 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05875974, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 27, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05875974 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →